Pharmaceutical Ingredients, Veterinary Drugs, Biopharmaceutical Products, Biopharmaceuticals
Diabetes Medications, Immunosuppressants, Antifungal Drugs, Antiviral Therapies, Antiviral Drugs, Anti-Tumor Medications, Cardiovascular Drugs, Active Pharmaceutical Ingredients (APIs), Oncology Drugs, Advanced Intermediates
BrightGene Bio-Medical Technology Co., Ltd. is a leading pharmaceutical company founded in 2001, specializing in innovative drug development, APIs, and complex preparations. The company focuses on international competition, particularly in high-tech fields such as antifungal, antiviral, anti-tumor, and cardiovascular drugs. BrightGene operates globally with certified GMP production facilities and a strong presence in the United States, EU, Japan, and South Korea. They are known for their pioneering drug development platforms and have been recognized for their contribution to healthcare innovations, including FDA-approved drugs.
